After adjusting for factors like age and cardiovascular disease, researchers found that people on GLP-1 drugs were 16% less likely to develop epilepsy
Tirzepatide ml dosing compared with brand-name pen doses Understanding how compounded tirzepatide ml doses correspond to brand-name pen doses (Mounjaro and Zepbound) helps you contextualize your protocol against the clinical trial data
We see an increase in CI activity and ATP production to support increased mitochondrial activity
Keep it away from heat, direct sunlight, and moisture
Harpreet Singh Bajaj, MD, MPH, an endocrinologist at LMC Diabetes & Endocrinology in Toronto, Canada, will present the primary results of the first phase 3 study of retatrutide in patients with type 2 diabetes, the TRANSCEND-T2D-1 trial